Shots: Censa to receive $10M in cash and up to 850,000 shares of PTC’s common stock as up front, $217.5M as development and regulatory milestones for two advanced programs along […]readmore
Tags : Acquire
Shots: Shots: Alexion to acquire all shares of Portola’s common stock at $18/ share in cash with a premium of 132%. Alexion will be acquiring cash currently on Portola’s balance […]readmore
Shots: AcelRx acquires Tetraphase in an all-stock transaction, at an exchange ratio of 0.6303 shares of AcelRx for each share of Tetraphase, or ~$14.4M as of Mar 13, 2020 and […]readmore
Shots: Bora acquires GSK’s facility located in Mississauga, Ontario (Canada) which produces ~50 products and employs ~400 skilled manufacturing staff. The transaction is expected to be completed in H2’20 As […]readmore
Shots: Thermo Fisher to acquire QIAGEN in an all-cash transaction for $43.3/ share, making a total deal value ~$11.5B with a premium of 23% to the closing price of QIAGEN’s […]readmore
Shots: Gilead to acquire Forty Seven in an all-cash transaction for $95.50/share, making a total deal value of ~$4.9B. The transaction is anticipated to be closed in Q2’20 The focus […]readmore
Shots: Medtronic acquires Digital Surgery to broaden its portfolio and to strengthen its robotic-assisted surgery platform. The acquisition will accelerate Medtronic’s strategy to provide AI and data within laparoscopic and […]readmore
Shots: Dr. Reddy’s acquires Wockhardt’s select divisions of its branded generics business in India and other international territories of Nepal, Sri Lanka, Bhutan and Maldives for ~$259M (Rs.1850 crores) The […]readmore
Shots: Valeritas to sell all its business to Zealand, in an all-cash transaction of ~$23M. Zealand will continue Valeritas’ commercially-focused operations and retain nearly all its employees For the smooth […]readmore
Shots: Assertio to receive $375M upfront in cash and fewer royalties in 2020, subject to certain adjustments. Collegium to get the US license or the Nucynta Franchise and will not […]readmore